BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18345298)

  • 1. Perioperative transfusion for pancreaticoduodenectomy and its impact on prognosis in resected pancreatic ductal adenocarcinoma.
    Clark E; Connor S; Taylor MA; Hendry CL; Madhavan KK; Garden OJ; Parks RW
    HPB (Oxford); 2007; 9(6):472-7. PubMed ID: 18345298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perioperative blood transfusion is associated with decreased survival in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma: a multi-institutional study.
    Sutton JM; Kooby DA; Wilson GC; Squires MH; Hanseman DJ; Maithel SK; Bentrem DJ; Weber SM; Cho CS; Winslow ER; Scoggins CR; Martin RC; Kim HJ; Baker JJ; Merchant NB; Parikh AA; Abbott DE; Edwards MJ; Ahmad SA
    J Gastrointest Surg; 2014 Sep; 18(9):1575-87. PubMed ID: 24944151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative lymphocyte count as a prognostic factor in resected pancreatic ductal adenocarcinoma.
    Clark EJ; Connor S; Taylor MA; Madhavan KK; Garden OJ; Parks RW
    HPB (Oxford); 2007; 9(6):456-60. PubMed ID: 18345294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resection margin status at the portomesenteric axis may not determine oncologic outcome after pancreaticoduodenectomy for lymph node-positive pancreatic ductal adenocarcinoma.
    Katou S; Wenning AS; Aeschbacher P; Morgul H; Becker F; Pascher A; Gloor B; Strücker B; Andreou A
    Surgery; 2023 Jul; 174(1):91-99. PubMed ID: 37121858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perioperative Red Blood Cell Transfusion Is Associated with Poor Long-term Survival in Pancreatic Adenocarcinoma.
    Abe T; Amano H; Hanada K; Minami T; Yonehara S; Hattori M; Kobayashi T; Fukuda T; Nakahara M; Ohdan H; Noriyuki T
    Anticancer Res; 2017 Oct; 37(10):5863-5870. PubMed ID: 28982913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Margin positive pancreaticoduodenectomy is superior to palliative bypass in locally advanced pancreatic ductal adenocarcinoma.
    Lavu H; Mascaro AA; Grenda DR; Sauter PK; Leiby BE; Croker SP; Witkiewicz A; Berger AC; Rosato EL; Kennedy EP; Yeo CJ
    J Gastrointest Surg; 2009 Nov; 13(11):1937-46; discussion 1946-7. PubMed ID: 19760308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Margin Status on Survival in Patients with Pancreatic Ductal Adenocarcinoma Receiving Neoadjuvant Chemotherapy.
    Schmocker RK; Delitto D; Wright MJ; Ding D; Cameron JL; Lafaro KJ; Burns WR; Wolfgang CL; Burkhart RA; He J
    J Am Coll Surg; 2021 Apr; 232(4):405-413. PubMed ID: 33338577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective assessment of resection margin status following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma after standardisation of margin definitions.
    Pine JK; Haugk B; Robinson SM; Darne A; Wilson C; Sen G; French JJ; White SA; Manas DM; Charnley RM
    Pancreatology; 2020 Apr; 20(3):537-544. PubMed ID: 31996296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse tumor biology associated with mesenterico-portal vein resection influences survival in patients with pancreatic ductal adenocarcinoma.
    Wang F; Gill AJ; Neale M; Puttaswamy V; Gananadha S; Pavlakis N; Clarke S; Hugh TJ; Samra JS
    Ann Surg Oncol; 2014 Jun; 21(6):1937-47. PubMed ID: 24558067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic influence of intrapancreatic tumor location on survival after resection of pancreatic ductal adenocarcinoma.
    Ruess DA; Makowiec F; Chikhladze S; Sick O; Riediger H; Hopt UT; Wittel UA
    BMC Surg; 2015 Nov; 15():123. PubMed ID: 26615588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case-matched comparison study of total pancreatectomy versus pancreaticoduodenectomy for patients with pancreatic ductal adenocarcinoma.
    Xiong J; Wei A; Ke N; He D; Chian SK; Wei Y; Hu W; Liu X
    Int J Surg; 2017 Dec; 48():134-141. PubMed ID: 29081373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A result of surgical treatment for ductal adenocarcinoma of the head of the pancreas].
    Moon HJ; Jang KT; Heo JS; Choi SH; Joh JW; Kim YI
    Korean J Gastroenterol; 2003 Aug; 42(2):156-63. PubMed ID: 14532721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
    Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS
    JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of resection for ductal adenocarcinoma of the pancreatic head].
    Morin B; Chiche L; Salame E; Lebreton G; Rouleau V; Segol P
    Ann Chir; 2006 Nov; 131(9):518-23. PubMed ID: 17045233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of blood transfusions and transfusion practices on long-term outcome following hepatopancreaticobiliary surgery.
    Ejaz A; Spolverato G; Kim Y; Margonis GA; Gupta R; Amini N; Frank SM; Pawlik TM
    J Gastrointest Surg; 2015 May; 19(5):887-96. PubMed ID: 25707813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative Alkaline Phosphatase-to-Cholesterol Ratio as a Predictor of Overall Survival in Pancreatic Ductal Adenocarcinoma Patients Undergoing Radical Pancreaticoduodenectomy.
    Qiu G; Zhang L; Gu Z; Ren H; Du Y; Li Z; Wang C
    Med Sci Monit; 2021 Oct; 27():e931868. PubMed ID: 34599137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripancreatic fat invasion is an independent predictor of poor outcome following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
    Jamieson NB; Foulis AK; Oien KA; Dickson EJ; Imrie CW; Carter R; McKay CJ
    J Gastrointest Surg; 2011 Mar; 15(3):512-24. PubMed ID: 21116727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative impact of fresh-frozen plasma transfusion on prognosis of pancreatic ductal adenocarcinoma after pancreatic resection.
    Shiba H; Misawa T; Fujiwara Y; Futagawa Y; Furukawa K; Haruki K; Iida T; Iwase R; Yanaga K
    Anticancer Res; 2013 Sep; 33(9):4041-7. PubMed ID: 24023348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic influence of resection margin clearance following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
    Jamieson NB; Chan NI; Foulis AK; Dickson EJ; McKay CJ; Carter CR
    J Gastrointest Surg; 2013 Mar; 17(3):511-21. PubMed ID: 23297028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor infiltration in the medial resection margin predicts survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
    Zhang Y; Frampton AE; Cohen P; Kyriakides C; Bong JJ; Habib NA; Spalding DR; Ahmad R; Jiao LR
    J Gastrointest Surg; 2012 Oct; 16(10):1875-82. PubMed ID: 22878786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.